Cargando…
Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is the most common autoimmune-autoinflammatory disease in childhood and affects approximately 1 in 1,000 children. Despite advances in diagnosis and treatment options, JIA remains a chronic condition for most affected children. Recent evidence suggests that diseas...
Autores principales: | Hayward, Kristen, Wallace, Carol A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688259/ https://www.ncbi.nlm.nih.gov/pubmed/19291269 http://dx.doi.org/10.1186/ar2619 |
Ejemplares similares
-
Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
por: Poddighe, Dimitri, et al.
Publicado: (2022) -
Non-Rheumatic Chronic Comorbidities in Children with Juvenile Idiopathic Arthritis
por: Haşlak, Fatih, et al.
Publicado: (2023) -
Juvenile idiopathic arthritis—recent advances
por: Rosendahl, Karen
Publicado: (2011) -
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
por: Grazziotin, Luiza R., et al.
Publicado: (2022) -
Recent advances in the treatment of juvenile idiopathic arthritis–associated uveitis
por: Chen, Judy L., et al.
Publicado: (2021)